These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18336237)

  • 1. Atheroprotective effects of HDL: beyond reverse cholesterol transport.
    Feig JE; Shamir R; Fisher EA
    Curr Drug Targets; 2008 Mar; 9(3):196-203. PubMed ID: 18336237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.
    Hersberger M; von Eckardstein A
    Drugs; 2003; 63(18):1907-45. PubMed ID: 12930163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low high-density lipoprotein cholesterol: current status and future strategies for management.
    Singh V; Sharma R; Kumar A; Deedwania P
    Vasc Health Risk Manag; 2010 Oct; 6():979-96. PubMed ID: 21127701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease.
    Besler C; Heinrich K; Riwanto M; Lüscher TF; Landmesser U
    Curr Pharm Des; 2010 May; 16(13):1480-93. PubMed ID: 20196740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action.
    Nagao M; Nakajima H; Toh R; Hirata KI; Ishida T
    J Atheroscler Thromb; 2018 Oct; 25(10):985-993. PubMed ID: 30146614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
    Chapman MJ
    Pharmacol Ther; 2006 Sep; 111(3):893-908. PubMed ID: 16574234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention.
    Parhofer KG
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):414-7. PubMed ID: 16151973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein and atherosclerosis: the role of antioxidant activity.
    Bandeali S; Farmer J
    Curr Atheroscler Rep; 2012 Apr; 14(2):101-7. PubMed ID: 22441969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis.
    Nofer JR; Brodde MF; Kehrel BE
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):726-35. PubMed ID: 20337657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
    Wierzbicki AS
    Curr Med Res Opin; 2005 Feb; 21(2):299-306. PubMed ID: 15802001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC; Duriez P
    Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications.
    Feig JE; Feig JL; Dangas GD
    Coron Artery Dis; 2016 Nov; 27(7):592-603. PubMed ID: 27414247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux and reverse cholesterol transport.
    Favari E; Chroni A; Tietge UJ; Zanotti I; Escolà-Gil JC; Bernini F
    Handb Exp Pharmacol; 2015; 224():181-206. PubMed ID: 25522988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions.
    Van Craeyveld E; Lievens J; Jacobs F; Feng Y; Snoeys J; De Geest B
    Gene Ther; 2009 Jun; 16(6):757-65. PubMed ID: 19242527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
    Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S
    Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New promising potential in fighting atherosclerosis: HDL and reverse cholesterol transport.
    Ginter E; Simko V
    Bratisl Lek Listy; 2013; 114(3):172-6. PubMed ID: 23406187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis.
    Farmer JA; Liao J
    Curr Atheroscler Rep; 2011 Apr; 13(2):107-14. PubMed ID: 21380938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing HDL-cholesterol and prevention of atherosclerosis: A critical perspective.
    Parhofer KG
    Atheroscler Suppl; 2015 May; 18():109-11. PubMed ID: 25936313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.